3-hydroxyflavone has been researched along with Acute Edematous Pancreatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abu Hashim, II; Awadeen, RH; Boughdady, MF; Elsaed, WM; Meshali, MM; Zaghloul, RA | 1 |
| Jia, R; Ma, J; Meng, W; Wang, N | 1 |
| Bae, GS; Choi, MO; Choi, SB; Jo, IJ; Kim, DG; Kim, TH; Park, SJ; Seo, SH; Shin, JY; Song, HJ | 1 |
3 other study(ies) available for 3-hydroxyflavone and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Formulation of lipid polymer hybrid nanoparticles of the phytochemical Fisetin and its in vivo assessment against severe acute pancreatitis.
Topics: Acute Disease; Animals; Drug Carriers; Drug Liberation; Flavonols; Lipids; Nanoparticles; Pancreatitis; Particle Size; Phytochemicals; Polymers; Rats | 2023 |
Dihydromyricetin inhibits caerulin-induced TRAF3-p38 signaling activation and acute pancreatitis response.
Topics: Acute Disease; Animals; Cell Death; Cell Survival; Cells, Cultured; Ceruletide; Cytokines; Flavonols; Macrophages; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Pancreatitis; Signal Transduction; TNF Receptor-Associated Factor 3 | 2018 |
Fisetin attenuates cerulein-induced acute pancreatitis through down regulation of JNK and NF-κB signaling pathways.
Topics: Acinar Cells; Acute Disease; Administration, Oral; Animals; Ceruletide; Down-Regulation; Enzyme Activation; Female; Flavonoids; Flavonols; Injections, Intraperitoneal; JNK Mitogen-Activated Protein Kinases; Lung; Mice; Mice, Inbred C57BL; NF-kappa B; Pancreas; Pancreatitis; Signal Transduction | 2014 |